SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trickle Portfolio
An SI Board Since October 2000
Posts SubjectMarks Bans
1784 65 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1534Q3 2003 Invitrogen Corporation Earnings Conference Call Boston, Oct 23, 2003 (Cmopgcw-10/23/2003
1533Though revenues were a bit light, PKI beats by a penny via improved gross margintuck-10/23/2003
1532TWTI beats by a penny as well. >>MADISON, Wis., Oct. 23 /PRNewswire-Firsttuck-10/23/2003
1531TECH beats by a penny or two (depending on whose consensus you're looking attuck-10/23/2003
1530Thanks for the transcripts, George. IVGN beats by 4 or 5 cents, guides up fortuck-10/23/2003
1529TMO: Message 19426236mopgcw-10/22/2003
1528sial part 3: Abe Brockentine, Glenview Capital - Analyst [70] --------------mopgcw-10/22/2003
1527SIAL prt 2: Dmitry Silversteyn, Longbow Research - Analyst [28] ------------mopgcw-10/22/2003
1526Q3 2003 Sigma-Aldrich Corporation Earnings Conference Call Boston, Oct 22, 2003mopgcw-10/22/2003
1525ABI part 4: Winton Gibbons, William Blair & Co. - Analyst [2] ---------mopgcw-10/22/2003
1524ABI prt 3: Meirav Chovav, UBS Warburg - Analyst [58] -----------------------mopgcw-10/22/2003
1523ABI prt 2: Derik DeBruin, UBS Warburg - Analyst [21] ----------------------mopgcw-10/22/2003
1522Q1 2004 Applied Biosystems and Celera Genomics Earnings Conference Call Boston,mopgcw-10/22/2003
1521WAT prt 3: Sara Michelmore, SG Cowan - Analyst [44] -------------------- Okmopgcw-10/22/2003
1520WAT Part 2: John Ornell, Waters Corporation - CFO [7] ---------------------mopgcw-10/22/2003
1519Q3 2003 Waters Corporation Earnings Conference Call Boston, Oct 22, 2003 (CCBN mopgcw-10/22/2003
1518AFFX beats by 25%, but doesn't provide outlook beyond 4Q03: >>SANTA Ctuck-10/22/2003
1517TMO beats, helped by ForEx and ex items. Here's the snip relevant to trickltuck-10/22/2003
1516BCOR takes charges associated with dropping Procel (that it got from Axiom, whictuck-10/22/2003
1515SIAL beat by a penny and reaffirmed FY03 guidance. Didn't say anything aboutuck-10/22/2003
1514DPII hits numbers, ups 4Q and FY03 guidance, and vaguely reaffirms '04: >tuck-10/22/2003
1513WAT reports in-line. Mass spec business weaker than HPLC. Can't remember ituck-10/22/2003
1512I won't have much time to dig deeply into earnings reports until later in thtuck-10/22/2003
1511>>ARLINGTON, Va., Oct. 22 /PRNewswire/ -- The market for protein and DNA ptuck-10/22/2003
1510>>NEW YORK, Oct. 20 (GenomeWeb News) - Genomic Solutions, a unit of Harvartuck-10/20/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News